Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Apimeds Pharmaceuticals US, Inc. (APUS) had Earnings per Share (EPS) (Basic) of $-0.26 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.66M |
|
-- |
|
-- |
|
$2.66M |
|
$-2.66M |
|
$0.00M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
10.37M |
|
10.37M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.26 |
$-0.26 |
|
| Balance Sheet Financials | |
$10.35M |
|
$0.01M |
|
$0.20M |
|
$10.55M |
|
$0.81M |
|
-- |
|
-- |
|
$0.81M |
|
$9.74M |
|
$9.74M |
|
$9.74M |
|
12.58M |
|
| Cash Flow Statement Financials | |
$-3.38M |
|
$-0.01M |
|
$12.13M |
|
$0.00M |
|
$8.74M |
|
$8.73M |
|
$1.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.79 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.34% |
|
-27.34% |
|
-25.24% |
|
-27.34% |
|
$0.77 |
|
$-0.33 |
|
$-0.33 |
|